Cutaneous T-cell lymphoma, unspecified

Clinical trials for Cutaneous T-cell lymphoma, unspecified explained in plain language.

Never miss a new study

Get alerted when new Cutaneous T-cell lymphoma, unspecified trials appear

Sign up with your email to follow new studies for Cutaneous T-cell lymphoma, unspecified, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Vitamin a derivative takes on tough lymphoma

Disease control Recruiting now

This early-stage trial is testing a new form of fenretinide (a vitamin A-like drug) given by IV for people with T-cell non-Hodgkin lymphoma that has come back or stopped responding to treatment. The study has two parts: first, finding the safest dose in small groups of patients, …

Matched conditions: CUTANEOUS T-CELL LYMPHOMA, UNSPECIFIED

Phase 1 • Sponsor: SciTech Development, Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:51 UTC

Cutaneous T-cell lymphoma, unspecified

Get alerted when new Cutaneous T-cell lymphoma, unspecified trials appear

Vitamin a derivative takes on tough lymphoma